Evaluating the Effects of Tasimelteon vs Placebo on Sleep Disturbances in SMS

NCT02231008 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

49

Enrollment

INDUSTRY

Sponsor class

Conditions

Smith-Magenis Syndrome
Circadian

Interventions

DRUG: tasimelteon
DRUG: placebo

Sponsor

Vanda Pharmaceuticals